Novel drug MLC901 underperforms against cognitive decline
        16 Apr 2021
    byTristan Manalac 
        NEURoaid II (MLC901), a traditional Chinese medicine-based neuroprotective intervention under investigation, is safe to administer in patients with vascular cognitive impairment no dementia (VCIND), but does not seem to grant significant cognitive benefits, according to a recent Singapore study.